A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)

NCT00692913 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

515

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: FOSAVANCE 5600 (Alendronate Sodium (+) cholecalciferol)
DIETARY_SUPPLEMENT: Calcium Supplement 500 mg
OTHER: Referred-Care Model

Sponsor

Organon and Co